Streptococcus pneumoniae is a leading cause of community-acquired pneumonia. Pneumococci are categorised into serotypes, based on the type of capsular polysaccharide produced, which has important implications for virulence, vaccine impact and global surveillance. In this study, the authors report and describe variants of serotype 33G, designated 33G-like, which they isolated from the nasopharynx of two adults hospitalised with pneumonia in Mongolia.
Featured article: Streptococcus pneumoniae serotype 33H: a novel serotype with frameshift mutations in the acetyltransferase gene wciG
Post-TB Sequelae
Edited by:
Gina Gualano: Infectious Diseases Unit, National Institute for Infectious Diseases Lazzaro Spallanzani (IRCC), Italy
Which children still die from pneumonia
Edited by:
Grant Austin Mackenzie: Medical Research Council, Gambia
Submission Status: Open until 30 June 2024
Articles
-
-
Changes in the incidence, viral coinfection pattern and outcomes of pneumococcal hospitalizations during and after the COVID-19 pandemic
-
Prevention of respiratory syncytial virus disease across the lifespan in Italy
-
Streptococcus pneumoniae serotype 33H: a novel serotype with frameshift mutations in the acetyltransferase gene wciG
-
High incidence of pneumonia cases observed in children seen in general practice consultations during the 2023–2024 season, France
-
Long-term effects of pneumonia in young children
-
The definition and classification of pneumonia
-
The role of co-infections and secondary infections in patients with COVID-19
-
The diagnosis of pneumonia requires a chest radiograph (x-ray)—yes, no or sometimes?
-
The radiological diagnosis of pneumonia in children
Sign up to receive article alerts
Pneumonia is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.
Aims and scope
Pneumonia is the only journal to focus exclusively on pneumonia. Publishing original research, case reports, reviews, commentaries and correspondence, Pneumonia provides an international forum for the exchange of knowledge by scientists and clinicians involved in studying the etiology and pathogenesis of pneumonia, as well as its diagnosis, epidemiology, treatment and prevention. The journal's scope extends to research on lung infections and diagnosis, inflammation and immunity, microbial pathogenesis and viral-bacterial interactions.
Cutting-edge research, insightful reviews and dedication to the community make Pneumonia an essential resource for clinicians, researchers, respirologists and allied professionals involved with infectious diseases.
Pneumonia archive
Pneumonia transferred to BioMed Central from Griffith University ePress in January 2016.
The archive of the journal has been transferred to a new platform and all articles previously published in the journal can be accessed here.
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 8.5
5-year Journal Impact Factor: 5.9
Source Normalized Impact per Paper (SNIP): N/A
SCImago Journal Rank (SJR): N/ASpeed 2024
Submission to first editorial decision (median days): 10
Submission to acceptance (median days): 160Usage 2024
Downloads: 245,232
Altmetric mentions: 110